Trotta Matteo 4
4 · INCYTE CORP · Filed Mar 27, 2024
Insider Transaction Report
Form 4
INCYTE CORPINCY
Trotta Matteo
EVP, GM, Dermatology US
Transactions
- Award
Common Stock
2024-03-25+7,828→ 7,828 total - Award
Employee Stock Option (right to buy)
2024-03-25+21,868→ 21,868 totalExercise: $57.48Exp: 2034-03-25→ Common Stock (21,868 underlying)
Footnotes (3)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Including the March 25, 2024 RSU Grant, this includes an aggregate of 7,828 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F3]The March 25, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.